130 related articles for article (PubMed ID: 33387348)
1. SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma.
Hlavac V; Vaclavikova R; Brynychova V; Dvorak P; Elsnerova K; Kozevnikovova R; Raus K; Kopeckova K; Mestakova S; Vrana D; Gatek J; Soucek P
Mol Diagn Ther; 2021 Jan; 25(1):99-110. PubMed ID: 33387348
[TBL] [Abstract][Full Text] [Related]
2. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.
Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V
Toxicol Sci; 2014 Nov; 142(1):196-209. PubMed ID: 25124723
[TBL] [Abstract][Full Text] [Related]
3. Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response.
Hlaváč V; Václavíková R; Brynychová V; Koževnikovová R; Kopečková K; Vrána D; Gatěk J; Souček P
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334016
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk.
Justenhoven C; Schaeffeler E; Winter S; Baisch C; Hamann U; Harth V; Rabstein S; Spickenheuer A; Pesch B; Brüning T; Ko YD; Schwab M; Brauch H
Breast Cancer Res Treat; 2011 Jan; 125(2):563-9. PubMed ID: 20635135
[TBL] [Abstract][Full Text] [Related]
5. Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
Snider H; Villavarajan B; Peng Y; Shepherd LE; Robinson AC; Mueller CR
Clin Epigenetics; 2019 Nov; 11(1):155. PubMed ID: 31675993
[TBL] [Abstract][Full Text] [Related]
6. Post-hatching ontogeny of intestinal proton-coupled folate transporter and reduced folate carrier in broiler chickens.
Jing M; Tactacan GB; House JD
Animal; 2013 Oct; 7(10):1659-64. PubMed ID: 23806361
[TBL] [Abstract][Full Text] [Related]
7. Identification of Prognostic Organic Cation and Anion Transporters in Different Cancer Entities by In Silico Analysis.
Edemir B
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599841
[TBL] [Abstract][Full Text] [Related]
8. Expression of Folate Pathway Genes in Stage III Colorectal Cancer Correlates with Recurrence Status Following Adjuvant Bolus 5-FU-Based Chemotherapy.
Odin E; Sondén A; Gustavsson B; Carlsson G; Wettergren Y
Mol Med; 2015 Jul; 21(1):597-604. PubMed ID: 26193446
[TBL] [Abstract][Full Text] [Related]
9. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
11. Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer.
Krus I; Brynychová V; Hlaváč V; Václavíková R; Kováčová M; Koževnikovová R; Kopečková K; Tornikidis J; Vrána D; Gatěk J; Souček P
Mol Diagn Ther; 2022 Nov; 26(6):665-678. PubMed ID: 36192583
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of proton-coupled folate transporter (SLC46A1) polymorphisms as risk factors for neural tube defects and oral clefts.
VanderMeer JE; Carter TC; Pangilinan F; Mitchell A; Kurnat-Thoma E; Kirke PN; Troendle JF; Molloy AM; Munger RG; Feldkamp ML; Mansilla MA; Mills JL; Murray JC; Brody LC
Am J Med Genet A; 2016 Apr; 170A(4):1007-16. PubMed ID: 26789141
[TBL] [Abstract][Full Text] [Related]
13. Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer.
Park YH; Shin HT; Jung HH; Choi YL; Ahn T; Park K; Lee A; Do IG; Kim JY; Ahn JS; Park WY; Im YH
Oncotarget; 2015 Oct; 6(31):32027-38. PubMed ID: 26397225
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
15. Association between SLCO1A2 genetic variation and methotrexate toxicity in human rheumatoid arthritis treatment.
Wang J; Yin J; Li W; Xiao C; Han J; Zhou F
J Biochem Mol Toxicol; 2020 Aug; 34(8):e22513. PubMed ID: 32304147
[TBL] [Abstract][Full Text] [Related]
16. First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2.
Ahlström S; Bergman P; Jokela R; Ottensmann L; Ahola-Olli A; Pirinen M; Olkkola KT; Kaunisto MA; Kalso E
Br J Anaesth; 2021 May; 126(5):949-957. PubMed ID: 33676726
[TBL] [Abstract][Full Text] [Related]
17. High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial.
Callens C; Debled M; Delord M; Turbiez-Stalain I; Veyret C; Bièche I; Brain E
Breast Cancer Res Treat; 2015 Sep; 153(2):383-9. PubMed ID: 26318989
[TBL] [Abstract][Full Text] [Related]
18. Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
Manoharan V; Karunanayake EH; Tennekoon KH; De Silva S; Imthikab AIA; De Silva K; Angunawela P; Vishwakula S; Lunec J
BMC Cancer; 2020 Jan; 20(1):72. PubMed ID: 32000721
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants of SLCO1B7 are of relevance for the transport function of OATP1B3-1B7.
Meyer Zu Schwabedissen HE; Seibert I; Grube M; Alter CL; Siegmund W; Hussner J
Pharmacol Res; 2020 Nov; 161():105155. PubMed ID: 32818652
[TBL] [Abstract][Full Text] [Related]
20. Predictive markers in elderly patients with estrogen receptor-positive breast cancer treated with aromatase inhibitors: an array-based pharmacogenetic study.
Rumiato E; Brunello A; Ahcene-Djaballah S; Borgato L; Gusella M; Menon D; Pasini F; Amadori A; Saggioro D; Zagonel V
Pharmacogenomics J; 2016 Nov; 16(6):525-529. PubMed ID: 26503812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
